Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO , May 15, 2024 (GLOBE NEWSWIRE) —  Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024 , the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,500 shares of its common stock to five new employees,